Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

 Gastro/
Procto/
Nutrition		 MICI Pancréas
A. LIEVRE V. VALANTIN I. ROSA P. JOUET S. NAHON V. REBOURS

V. HAUTEFEUILLE
N. WILLIET
N. FARES
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
PE. RAUTOU

H. DAMON
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre croissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Disease mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity avr. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Intestinal Dilation and Platelet:Albumin Ratio Are Predictors of Surgery in Stricturing Small Bowel Crohn's Disease aoû. 16 3 ♥ MICI, Chirurgie
Clinical Gastroenterology and Hepatology Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed oct. 17 2 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease. mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Consumption of Red and Processed Meat and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis avr. 17 3 ♥ Pancréas/voies bilaires
Clinical Gastroenterology and Hepatology Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Education, Employment, Income, and Marital Status Among Adults Diagnosed With Inflammatory Bowel Diseases During Childhood or Adolescence avr. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Characteristics and Progression of Preclinical Inflammatory Bowel Disease. sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Jan. 16 3 ♥ MICI
Inflammatory Bowel Diseases Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis. avr. 16 4 ♥ MICI
Inflammatory Bowel Diseases Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease aoû. 16 3 ♥ Intestin/Nutrition/Troubles fonctionnels
Inflammatory Bowel Diseases Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization oct. 15 2 ♥ MICI
Inflammatory Bowel Diseases Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies aoû. 16 3 ♥ MICI
Inflammatory Bowel Diseases The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure avr. 17 2 ♥ MICI
Inflammatory Bowel Diseases Capsule Endoscopy: Diagnostic Accuracy of Lewis Score in Patients with Suspected Crohn's Disease oct. 15 2 ♥ MICI
Inflammatory Bowel Diseases Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis aoû. 16 2 ♥ MICI
Inflammatory Bowel Diseases Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study avr. 17 2 ♥ MICI
Inflammatory Bowel Diseases Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study Gaurav avr. 17 3 ♥ MICI
Inflammatory Bowel Diseases The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease juin. 17 3 ♥ MICI
Inflammatory Bowel Diseases 2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial mai. 17 2 ♥ MICI
Inflammatory Bowel Diseases Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. oct. 18 3 ♥ Coloproctologie
Inflammatory Bowel Diseases Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review. mai. 17 4 ♥ Coloproctologie

Pages